Is the use of warfarin becoming obsolete? by Tarek Haykal, Smit S. Deliwala, Thomas L. Ortel

Get full text

Racial differences in venous thromboembolism: A surveillance program in Durham County, North Carolina by Ibrahim Saber, Alys Adamski, Maragatha Kuchibhatla, Karon Abe, Michele Beckman, Nimia Reyes, Ryan Schulteis, Bhavana Pendurthi Singh, Andrea Sitlinger, Elizabeth H. Thames, Thomas L. Ortel

Get full text

Systems Pharmacogenomics Finds RUNX1 Is an Aspirin-Responsive Transcription Factor Linked to Cardiovascular Disease and Colon Cancer by Deepak Voora, MD, A. Koneti Rao, MD, Gauthami S. Jalagadugula, PhD, Rachel Myers, PhD, Emily Harris, Thomas L. Ortel, MD, PhD, Geoffrey S. Ginsburg, MD, PhD

Get full text

Influence of Sex on Platelet Reactivity in Response to Aspirin by Kevin A. Friede, Margaret M. Infeld, Ru San Tan, Holly J. Knickerbocker, Rachel A. Myers, Laura G. Dubois, J. Will Thompson, Rima Kaddurah‐Daouk, Geoffrey S. Ginsburg, Thomas L. Ortel, Deepak Voora

Get full text

Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiative by David A. Wohl, Stacey J. Adam, Kevin W. Gibbs, Ari L. Moskowitz, Thomas L. Ortel, Upinder Singh, Nikolaus Jilg, Teresa H. Evering, William A. Fischer, Babafemi O. Taiwo, Eric S. Daar, Christopher J. Lindsell, Susanna Naggie, Russell L. Rothman, Sarah E. Dunsmore, M. Patricia McAdams, Julia Vail, Dushyantha Jayaweera

Get full text